PD-L1/IDO peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-L1/IDO peptide vaccine, covering 2025-02-20 to 2025-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma [Phase 1, Phase 2]